The News: The Wall Street Journal reports that the pace of biotech IPOs in on track for a near-record year, although many are riskier due to being in earlier stages of development…. Read more »
The News: Theranos, the humiliated, disintegrating, and allegedly fraud- packed blood-testing startup, is most often related to its founder and CEO, Elizabeth Holmes. But during the rise and fall of… Read more »
The News: A former Insys Therapeutics Inc. (Chandler AZ) sales representative was recently sentenced to six months of home confinement after admitting that she participated in a scheme to pay… Read more »
The News: Senate GOP leaders plan a last-ditch floor vote on their bill as soon as Thursday (November 30, 2017)–a dramatic moment that will come only after a marathon debate…. Read more »
The News: Shortly after Senate Majority Leader Mitch McConnell unveiled a revised bill last Thursday to overhaul the US healthcare system, lawmakers undecided about the proposed changes to Medicaid gathered together… Read more »
The News: Just ahead of the year’s biggest download of cancer data, the maker of a closely watched drug has put itself up for sale, according to The Wall Street… Read more »
Mylan NV (Amsterdam) is facing a new class-action lawsuit related to the price hikes of it EpiPen devices. The lawsuit was filed in federal court in Tacoma, Washington on Monday… Read more »
Entrepreneur Elon Musk has confirmed on via Twitter the launch of a new venture company, called Neuralink, which aims to develop a brain-computer interface. According to people familiar with the matter, the company will pursue what… Read more »
On Thursday (March 23, 2017), the Wall Street Journal posted another seminal report from inside the tattered remains of biomedical company Theranos Inc. (Palo Alto CA). The company, which is… Read more »
The News: Activist investor Carl Icahn just announced his latest target: Bristol-Myers Squibb Co., reports the Wall Street Journal. Bristol-Myers has been the focus of several activist investors in recent… Read more »
